Lipoprotein lipase stimulation

Decreased gluconeogenesis Increased glucose transport into cells Induction of lipoprotein lipase Stimulation of glycogenolysis... 

TNF (17.5) Monocyte/macrophage, lymphocyte, neutrophil, endothelium, fibroblast, keratinocyte Activation of T and B cells, natural killer cells, neutrophils, and osteoblasts. Stimulation of endothelial cells to release chemotactic proteins, NO and PGI2. Tumoricidal activity. Induces fever, sleep, hepatic acute phase protein synthesis, catabolism, ACTH release. Lead to myocardial depression, hypotension/shock, hypercoagulability, and death. Stimulates production of IL-1, IL-6, IL-8, IFN-y, and H202. Suppression of cytochrome P-450, thyroglobulin, and lipoprotein lipase. Induces complement activation, release of eicosanoids, including PAF. Procoagulant activity. 

Lipid and lipoprotein acylation stimulating protein, lipoprotein lipase. 

VLDLs, IDLs, and LDLs are closely related to one another. VLDLs formed in the liver (see p. 312) transport triacylglycerols, cholesterol, and phospholipids to other tissues. Like chylomicrons, they are gradually converted into IDL and LDL under the influence of lipoprotein lipase [1]. This process is also stimulated by HDL. Cells that have a demand for cholesterol bind LDL through an interaction between their LDL receptor and ApoB-100, and then take up the complete particle through receptor-mediated endocytosis. This type of transport is mediated by depressions in the membrane ( coated pits"), the interior of which is lined with the protein clathrin. After LDL binding, clathrin promotes invagination of the pits and pinching off of vesicles ( coated vesicles"). The clathrin then dissociates off and is reused. After fusion of the vesicle with ly-sosomes, the LDL particles are broken down (see p. 234), and cholesterol and other lipids are used by the cells. 

Partial summary of lipoprotein metabolism in humans. I to VII are sites of action of hypolipidemic drugs. I, stimulation of bile acid and/or cholesterol fecal excretion II, stimulation of lipoprotein lipase activity III, inhibition of VLDL production and secretion IV, inhibition of cholesterol biosynthesis V, stimulation of cholesterol secretion into bile fluid VI, stimulation of cholesterol conversion to bile acids VII, increased plasma clearance of LDL due either to increased LDL receptor activity or altered lipoprotein composition. CHOL, cholesterol IDL, intermediate-density lipoprotein. 

Progesterone has little effect on protein metabolism. It stimulates lipoprotein lipase activity and seems to favor fat deposition. The effects on carbohydrate metabolism are more marked. Progesterone increases basal insulin levels and the insulin response to glucose. There is... 

Fibrates like gemfibrozil, clofibrate, ciprofibrate, etc. are fibric acid derivatives which stimulate lipoprotein lipase, an enzyme that breaks down lipids in lipoproteins and causes an increase in the hydrolysis of... 

In human adipose tissue, palmitoyl-CoA is usually used in the first glycerol-3-phosphate acylation reaction. The next two acyl residues are normally unsaturated fatty acids oleic acid and, less commonly, linoleic acid. Triglyceride biosynthesis is stimulated by insulin, most likely via its activation of lipoprotein lipase and its activity in moving glucose into the cells. 

Human milk differs from cows milk in that it contains two lipases, a lipoprotein lipase and a bile salt-stimulated lipase. The ability of the latter to cause considerable hydrolysis of ingested milk lipids has important nutritional implications. 

There were several new developments during the 1970s. Of particular importance was the purification and characterization of a lipoprotein lipase (LPL) and the acceptance of the postulate that this was the major, if not the only, lipase in cows milk (Olivecrona, 1980). Similarly, the elucidation of the lipase system in human milk as consisting of an LPL and a bile salt-stimulated lipase, and the possible role of the latter in infant nutrition, were noteworthy (Fredrikzon et al, 1978). Also, microbial lipolysis assumed substantial significance with the widespread use of low-temperature storage of raw milk and the recognition that heat-stable lipases produced by psychrotrophic bacteria were a major cause of flavor problems in stored dairy products (Law, 1979). 

Other factors. A cow s hormonal balance can affect the susceptibility of her milk to spontaneous lipolysis (Fredeen et al., 1951 Kastli et al., 1967 Bachman et al., 1988). The oestrus cycle appears to have little effect on spontaneous lipolysis (Fredeen et al, 1951) but may affect lipase activity in the milk (Kelly, 1945). In contrast, treatment of cows with oestradiol and progesterone has been shown to lead to increased lipolysis in the milk (Bachman, 1982 Heo, 1983 Bachmann eta/., 1985) but no change (Bachman, 1982) or a transient increase (Bachmann et al., 1985) in total lipase activity. It appears that the increased lipolysis in milk following hormonal treatment, or in milk from cows with ovarian cysts, may not be typical spontaneous lipolysis as cooling is not needed to initiate it (Bachman, 1982) a lipase other than lipoprotein lipase, possibly a bile salt-stimulated lipase, may be responsible for such lipolysis (Heo, 1983 Bachmann et al., 1985). Treatment of cows with bovine somatotropin has been reported to have no significant effect on milk lipoprotein lipase activity (Azzara et al., 1987). 

Insulin, among other things, also stimulates production of lipoprotein lipase (LPL). With insulin deficiency in diabetes, there is insufficient LPL to release fatty acids from the triglycerides of VLDL and chylomicrons (see Fig. 6.4), another reason for accumulating serum triglycerides, apart from increased VLDL production by the liver. 

The liver synthesizes two enzymes involved in intra-plasmic lipid metabolism hepatic triglyceride lipase (HTL) and lecithin-cholesterol-acyltransferase (LCAT). The liver is further involved in the modification of circulatory lipoproteins as the site of synthesis for cholesterol-ester transfer protein (CETP). Free fatty acids are in general potentially toxic to the liver cell. Therefore they are immobilized by being bound to the intrinsic hepatic fatty acid-binding protein (hFABP) in the cytosol. The activity of this protein is stimulated by oestrogens and inhibited by testosterone. Peripheral lipoprotein lipase (LPL), which is required for the regulation of lipid metabolism, is synthesized in the endothelial cells (mainly in the fatty tissue and musculature). 

The storage of triacylglycerols in adipose tissue is mediated by insulin, which stimulates adipose cells to secrete lipoprotein lipase and to take up glucose, the source of glycerol for triacylglycerol synthesis. 

Figure 6-9. Regulation of triacylglycerol stores in adipose tissue. Left = in the fed state. Right = in the fasted state. TG = triacylglycerol FA = fatty acid LPL = lipoprotein lipase DHAP = dihydroxyacetone phosphate = stimulated by circled TG = triacylglycerol of chylomicrons and VLDL.

Figure 6-10. Metabolism of chylomicrons and VLDL. LPL = lipoprotein lipase TG = triacylglycerol CE = cholesterol esters circled TG - triacylglycerol of chylomicrons and VLDL 0= inhibits = stimulates.

C. VLDL levels are elevated because the decreased insulin and increased glucagon cause lipolysis of adipose triacylglycerols. The fatty acids and glycerol are repackaged in VLDL, which are secreted by the liver. Therefore, both triacylglycerols and cholesterol are elevated in the blood. Lipoprotein lipase is decreased because its synthesis and secretion by adipose tissue are stimulated by insulin. 

---